Folgen
James Allison
James Allison
MD Anderson Cancer Center
Keine bestätigte E-Mail-Adresse
Titel
Zitiert von
Zitiert von
Jahr
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber, EJ Wherry, D Masopust, B Zhu, JP Allison, AH Sharpe, ...
Nature 439 (7077), 682-687, 2006
43662006
Enhancement of antitumor immunity by CTLA-4 blockade
DR Leach, MF Krummel, JP Allison
Science 271 (5256), 1734-1736, 1996
38701996
The future of immune checkpoint therapy
P Sharma, JP Allison
Science 348 (6230), 56-61, 2015
36862015
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ...
Science 359 (6371), 97-103, 2018
27072018
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
MF Krummel, JP Allison
The Journal of experimental medicine 182 (2), 459-465, 1995
24431995
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
FA Harding, JG McArthur, JA Gross, DH Raulet, JP Allison
Nature 356 (6370), 607-609, 1992
20961992
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival
BC Özdemir, T Pentcheva-Hoang, JL Carstens, X Zheng, CC Wu, ...
Cancer cell 25 (6), 719-734, 2014
19312014
Immunologic correlates of the abscopal effect in a patient with melanoma
MA Postow, MK Callahan, CA Barker, Y Yamada, J Yuan, S Kitano, Z Mu, ...
New England Journal of Medicine 366 (10), 925-931, 2012
19122012
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
P Sharma, JP Allison
Cell 161 (2), 205-214, 2015
18722015
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan, JC Yang, RM Sherry, P Hwu, SL Topalian, ...
Proceedings of the National Academy of Sciences 100 (14), 8372-8377, 2003
18152003
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
MA Curran, W Montalvo, H Yagita, JP Allison
Proceedings of the National Academy of Sciences 107 (9), 4275-4280, 2010
18082010
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
MM Gubin, X Zhang, H Schuster, E Caron, JP Ward, T Noguchi, Y Ivanova, ...
Nature 515 (7528), 577-581, 2014
17882014
Fundamental Mechanisms of Immune Checkpoint Blockade TherapyFundamental Mechanisms of Immune Checkpoint Blockade Therapy
SC Wei, CR Duffy, JP Allison
Cancer discovery 8 (9), 1069-1086, 2018
17342018
Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells
SE Townsend, JP Allison
Science 259 (5093), 368-370, 1993
15891993
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research
MA Cheever, JP Allison, AS Ferris, OJ Finn, BM Hastings, TT Hecht, ...
Clinical cancer research 15 (17), 5323-5337, 2009
13862009
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
TR Simpson, F Li, W Montalvo-Ortiz, MA Sepulveda, K Bergerhoff, F Arce, ...
Journal of Experimental Medicine 210 (9), 1695-1710, 2013
13372013
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative …
RPM Sutmuller, LM Van Duivenvoorde, A Van Elsas, TNM Schumacher, ...
The Journal of experimental medicine 194 (6), 823-832, 2001
12442001
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
H Matsushita, MD Vesely, DC Koboldt, CG Rickert, R Uppaluri, VJ Magrini, ...
Nature 482 (7385), 400-404, 2012
11912012
Combination immunotherapy of B16 melanoma using anti–cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF …
A Van Elsas, AA Hurwitz, JP Allison
The Journal of experimental medicine 190 (3), 355-366, 1999
11731999
CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy
CA Chambers, MS Kuhns, JG Egen, JP Allison
Annual review of immunology 19, 565, 2001
11552001
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20